Recently, Roche Molecular Diagnostics announced that the US Food and Drug Administration (FDA) has approved its latest HIV load tester and will be available later this year in the U.S. market.
It is understood that Roche's latest dual-site HIV load test has ensured the reliability of results, and it is confident even in the face of the rapidly growing diversity of HIV-1 genes. This approach allows direct targeting of two highly conserved regions of the HIV-1 genome while avoiding current drug targets in any other region, allowing the detector to detect even in rare cases where mutations or probe binding sites do not match. Can also provide reliable test results. Since Roche first introduced the innovative approach of dual targets into highly effective antiretroviral therapy for HIV-1 patients, more than 8 million HIV tests have been performed on the Roche highly-integrated fully-automated PCR platform worldwide.
The FDA's approval of Roche's latest HIV test will bring more gospel to the labs, clinicians, and patients. Roche has been working to develop diagnostic tools such as the dual-target HIV test. Its purpose is to help improve the doctor's ability to monitor the virus so that it can take appropriate treatment options for people living with HIV.
It is understood that Roche's latest dual-site HIV load test has ensured the reliability of results, and it is confident even in the face of the rapidly growing diversity of HIV-1 genes. This approach allows direct targeting of two highly conserved regions of the HIV-1 genome while avoiding current drug targets in any other region, allowing the detector to detect even in rare cases where mutations or probe binding sites do not match. Can also provide reliable test results. Since Roche first introduced the innovative approach of dual targets into highly effective antiretroviral therapy for HIV-1 patients, more than 8 million HIV tests have been performed on the Roche highly-integrated fully-automated PCR platform worldwide.
The FDA's approval of Roche's latest HIV test will bring more gospel to the labs, clinicians, and patients. Roche has been working to develop diagnostic tools such as the dual-target HIV test. Its purpose is to help improve the doctor's ability to monitor the virus so that it can take appropriate treatment options for people living with HIV.
SunGOOD has professional experience in fabricate all kinds of brewing equipments and brewing systems, such as 1bbl-30bbl 5bbl Brewery Equipment which can be 100L to 5000L, we can also produce distilling and brewing Fermentation Tanks, brite tanks, Mash Tun , lauter tun, Brew Kettle, etc.
Beer Brewing Equipment,brewing equipment,micro brewing equipment,brew house,brewhouse,beer brewery equipment
Wenzhou Deli Machinery Equipment Co., Ltd. , https://www.sungoodtech.com